Propynyl (drug)
![]() | |
| Clinical data | |
|---|---|
| Other names | PROPYNYL; 4-Propynyloxy-3,5-dimethoxyphenethylamine; Propynylmescaline; Propynylscaline |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 8–12 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H17NO3 |
| Molar mass | 235.283 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Propynyl, also known as 4-propynyloxy-3,5-dimethoxyphenethylamine or as propynylscaline, is a lesser-known drug of the scaline family. It is closely related in structure to mescaline. Propynyl was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 80 mg, and the duration listed as 8–12 hours.[1] Propynyl produces a body load and few to no mental effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of propynyl. It is not a controlled substance in Canada as of 2025.[2]
See also
References
- ^ a b c Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. Propynyl entry
- ^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.
.svg.png)